Jeffrey W. Sherman, Director at Xeris Biopharma Holdings, Inc. (XERS), sold 84,464 shares at $7.92 ($669K) on 2025-08-28, disclosed to the SEC on 2025-08-29.
Open-market sale of $669k XERS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.92 | 42,232 | $334K | 50.0% |
| 2 | $7.92 | 42,232 | $334K | 50.0% |
| Total | $7.92 avg | 84,464 | $669K | 100% |
| Filing → |
| HZNP | SELL | 2023-01-12 | $1.5M | — | Filing → |
| HZNP | SELL | 2023-01-06 | $1.2M | — | Filing → |
| HZNP | SELL | 2022-12-13 | $6.3M | — | Filing → |